Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Gastroenterology Conference 2026

Welcome Message

Dear Esteemed Participants,

On behalf of the organizing committee, it is our great pleasure to welcome you to the 5th International Conference on Gastroenterology and Liver, scheduled for June 29–30, 2026, in Paris, France.

This year’s conference will unite global experts in gastroenterology, hepatology, internal medicine, and digestive health to share the latest advancements, innovative research, and transformative approaches in the prevention, diagnosis, and management of gastrointestinal and liver disorders. With digestive and hepatic diseases posing major global health challenges, this conference serves as a vital platform for collaboration and innovation toward improving clinical outcomes and advancing patient care.

Whether you are joining as a speaker, delegate, researcher, or exhibitor, we invite you to actively participate in discussions, network with peers, and contribute to the collective vision of advancing gastroenterology and liver medicine worldwide.

We look forward to welcoming you to Paris for an engaging experience filled with learning, inspiration, and global collaboration.

Warm regards,
Organizing Committee

About Conference


The 5th International Conference on Gastroenterology and Liver will be held on June 29–30, 2026, in Paris, France, under the theme “Innovations in Gastroenterology and Liver Care: Advancing Research, Treatment, and Global Health.”

This global event brings together leading scientists, clinicians, surgeons, researchers, academicians, and healthcare professionals dedicated to improving gastrointestinal and hepatic health. The conference will feature keynote sessions, symposia, workshops, and interactive panels covering a broad spectrum of topics — including gastrointestinal oncology, endoscopic innovations, liver transplantation, microbiome research, viral hepatitis, metabolic liver diseases, and advancements in non-invasive diagnostics.

By integrating clinical expertise with research insights, the event aims to bridge the gap between scientific discovery and real-world application, fostering new partnerships that will shape the future of gastroenterology and hepatology.

Conference Agenda

Registration & Welcome Kit: Delegates will begin by registering and collecting conference kits, badges, and the detailed program. Early check-in is encouraged for a smooth start.

Opening Ceremony & Keynote Session: The conference opens with welcome remarks from the organizing committee, followed by keynote addresses from global experts in gastroenterology and hepatology.

Scientific Sessions: Parallel sessions will explore topics such as inflammatory bowel disease, liver fibrosis, gastrointestinal cancers, endoscopic advancements, liver regeneration, and gut microbiome research.

Poster & E-Poster Presentations: Researchers and students will present innovative studies during interactive poster walks and digital poster sessions, fostering engagement and feedback.

Networking Breaks & Exhibition: Tea/coffee breaks and industry exhibitions will provide opportunities to interact with fellow participants, explore products, and build collaborations.

Conference Lunch & Closing Ceremony: Delegates can connect over lunch while exchanging ideas. On the final day, best oral and poster awards will be presented, followed by certificates and closing remarks.

Optional Activities: Special networking dinners and guided Paris city tours will offer attendees a blend of cultural experience and professional engagement.

Why to Attend

Because gastrointestinal and liver health lies at the heart of global well-being.

The 5th International Conference on Gastroenterology and Liver goes beyond presentations — it’s a global movement dedicated to transforming digestive and hepatic medicine. Attendees will gain firsthand access to the latest clinical trials, groundbreaking diagnostic tools, and future-ready therapeutic innovations.

This conference provides a unique opportunity to exchange ideas with world-renowned experts, challenge conventional practices, and explore the role of precision medicine, AI, and biotechnology in shaping the next era of gastroenterology and hepatology.

Join us to contribute, collaborate, and create meaningful impact in advancing global digestive health.

Participation / Presentation Options

We offer diverse participation formats to ensure a rich and inclusive experience for all attendees:

  • Oral Presentation (In-Person): Share your latest research and clinical findings with a live audience.
  • Poster Presentation (In-Person): Showcase your work visually and engage in one-on-one discussions.
  • E-Poster Presentation (Virtual): Display your research digitally for global visibility.
  • Video Presentation (Virtual): Submit pre-recorded talks for inclusion in the virtual gallery.
  • Webinar Presentation (Live Virtual): Present remotely in real-time to a worldwide audience.
  • Panel Discussion: Join expert-led panels to exchange perspectives on emerging healthcare issues.
  • Workshop Facilitation: Lead interactive sessions focused on new techniques or technologies.
  • Lightning Talk: Deliver short, impactful presentations on innovative research ideas.
  • Listener / Delegate (In-Person or Virtual): Engage, learn, and network without presenting.
  • Young Researcher Forum: A dedicated platform for early-career professionals to present and connect with mentors.
 

 

Market Analysis

The global gastroenterology and hepatology market is experiencing rapid growth, driven by increasing prevalence of digestive and liver disorders, lifestyle-related diseases, and advancements in medical technology.

The global gastrointestinal therapeutics market is projected to exceed USD 70 billion by 2030, fueled by innovations in biologics and personalized medicine.

The liver disease diagnostics and treatment market is expected to grow at a CAGR of over 6%, driven by rising cases of non-alcoholic fatty liver disease (NAFLD), hepatitis, and liver cancer.

Endoscopy and minimally invasive technology adoption continues to expand, enhancing early detection and patient recovery rates.

Microbiome-based therapies and AI-driven diagnostic tools are emerging as transformative solutions in digestive healthcare.

Increasing awareness of preventive gastroenterology and liver health programs is fostering new opportunities in both clinical and research sectors.

The conference provides a strategic platform for medical professionals, researchers, and industry stakeholders to align with these evolving trends and contribute to global progress in gastrointestinal and liver health.

 

To Collaborate Scientific Professionals around the World

Conference Date June 29-30, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Liver Journal of Gastrointestinal & Digestive System Journal of Hepatology and Gastrointestinal disorders

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Advances In Pharmacology And Therapeutics
  • AI And Machine Learning In Endoscopy And Diagnostics
  • Alcoholic Liver Disease
  • Artificial Liver Support Systems
  • Ascites And Fluid Management In Cirrhosis
  • Autoimmune Hepatitis
  • Big Data And Predictive Modeling In Hepatology
  • Biliary Tract Diseases And Gallstone Disorders
  • Biologics And Small Molecule Therapies In GI And Liver Care
  • Capsule Endoscopy And Imaging Advances
  • Celiac Disease And Gluten-related Disorders
  • Cholangiocarcinoma ? Diagnostics And Therapy
  • Chronic Liver Disease ? Overview And Global Burden
  • Cirrhosis ? Pathogenesis And Complications
  • Clinical Trials In Gastroenterology And Hepatology
  • Colorectal Cancer Screening And Management
  • Digital Health And Wearable Monitoring In GI Disorders
  • Education, Training, And Professional Development In Gastroenterology
  • Endoscopic Ultrasound (EUS) And Advanced Imaging
  • Environmental And Occupational Liver Diseases
  • Esophageal Cancer Diagnostics And Therapy
  • Ethics, Policy, And Healthcare Economics In Gastroenterology And Hepatology
  • Fecal Microbiota Transplantation (FMT) In GI And Liver Disorders
  • Food Intolerances And Allergic Disorders Of The Gut
  • Functional Dyspepsia
  • Gastric Cancer ? Molecular Targets And Therapies
  • Gastroesophageal Reflux Disease (GERD)
  • Gastrointestinal Bleeding And Hemostasis
  • Gastrointestinal Endoscopy ? Diagnostic Innovations
  • Gastrointestinal Endoscopy ? Therapeutic Techniques
  • Gastrointestinal Infections And Tropical Diseases
  • Gastrointestinal Motility And Neurogastroenterology
  • Gastrointestinal Stromal Tumors (GISTs)
  • Gastrointestinal Surgery And Minimally Invasive Approaches
  • Gene Therapy And Molecular Approaches To Liver Disease
  • Genetic And Metabolic GI Disorders
  • Geriatric Gastroenterology And Aging GI System
  • GI Complications Of Systemic Diseases (diabetes, Cardiovascular, Autoimmune)
  • Global Burden Of GI And Liver Cancers
  • Gut Microbiome In Health And Disease
  • Gut?liver Axis And Systemic Disorders
  • Hemochromatosis And Iron-related Liver Conditions
  • Hepatic Encephalopathy And Management
  • Hepatitis B ? Diagnostics And Management
  • Hepatitis C ? Elimination Strategies
  • Hepatitis D And Co-infections
  • Hepatobiliary Cancers And Interventions
  • Hepatocellular Carcinoma (HCC) ? Advances In Treatment
  • Immunotherapy In GI And Liver Cancers
  • Inflammatory Bowel Disease (IBD) ? Crohn?s Disease
  • Inflammatory Bowel Disease (IBD) ? Ulcerative Colitis
  • Inherited Gastrointestinal Polyposis Syndromes
  • Irritable Bowel Syndrome (IBS)
  • Liver Fibrosis And Antifibrotic Therapies
  • Liver Metastases ? Clinical Approaches
  • Liver Transplantation ? Clinical Practice Updates
  • Living Donor Liver Transplantation
  • Neonatal Gastrointestinal And Hepatic Conditions
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Non-alcoholic Steatohepatitis (NASH)
  • Nutrition, Diet, And Lifestyle In GI Health
  • Obesity And Bariatric Surgery In GI Health
  • Palliative Care And Quality Of Life In GI And Liver Diseases
  • Pancreatic Cancer And Novel Treatment Approaches
  • Pancreatitis ? Acute And Chronic Management
  • Pediatric Gastroenterology And Liver Disorders
  • Pediatric Hepatology ? Genetic And Rare Disorders
  • Peptic Ulcer Disease
  • Personalized Approaches In Gastroenterology
  • Pharmacogenomics In Gastroenterology And Hepatology
  • Portal Hypertension And Variceal Bleeding
  • Precision Medicine And Biomarkers In Hepatology
  • Probiotics, Prebiotics, And Microbiota-based Therapies
  • Public Health And Global Strategies For Viral Hepatitis
  • Rare GI Tumors And Unusual Case Presentations
  • Regenerative Medicine And Stem Cell Therapy In Hepatology
  • Telemedicine And Remote Patient Management
  • Translational Research And Bench-to-bedside Models
  • Viral Hepatitis A And E
  • Wilson?s Disease And Metabolic Liver Disorders